Profile - To The Moon

NicholasTK

Posts · 12Posts · 12
Following · 0Following · 0
Followers · 0Followers · 0

- NicholasTKNicholasTK
  ·2022-01-20
  Like
  Sorry, this post has been deleted
  1.79K Comment
  Like
  Share
  Report
- NicholasTKNicholasTK
  ·2021-12-26
  Like
  Sorry, this post has been deleted
  1.94K Comment
  2
  Share
  Report
- NicholasTKNicholasTK
  ·2021-09-17
  $PING AN(02318)$So much cash but still can’t stop your stock to plummet, it is a given to hold but still heartbreaking
  2.53K 5
  Like
  Share
  Report
- NicholasTKNicholasTK
  ·2021-09-11
  Like me :)
  Why Apple’s Risk Is Limited
  Apple faces real, but limited, risk to its revenue and profits from Friday’s ruling that requires it to allow developers to offer alternative payment methods for purchases made in apps downloaded through the Apple app store.In a case filed by Fortnite publisher Epic Games, U.S. District Judge Yvonne Gonzalez Rogers issued a permanent injunction that requires Apple to allow developers the option to include links to alternative payment methods in their apps. Apple’s own payment system takes a 30%
  Why Apple’s Risk Is Limited
  2.77K 1
  3
  Share
  Report
- NicholasTKNicholasTK
  ·2021-09-03
  Just cause of some rare cases happening doesntmean jack lol
  EMA Says Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot
  EMA:Ema: Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (Prac) 30 August –
  EMA Says Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot
  1.56K Comment
  5
  Share
  Report
- NicholasTKNicholasTK
  ·2021-08-31
  $NEW ORIENTAL-S(09901)$Yeet
  2.27K 1
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"4088932361408620","uuid":"4088932361408620","gmtCreate":1625829316592,"gmtModify":1706620741480,"name":"NicholasTK","pinyin":"nicholastk","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":2,"tweetSize":12,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.58%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"60.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9004468887,"gmtCreate":1642664644650,"gmtModify":1676533733673,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004468887","repostId":"1193556114","repostType":4,"isVote":1,"tweetType":1,"viewCount":1794,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009329420,"gmtCreate":1640512892933,"gmtModify":1676533523927,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009329420","repostId":"2193178197","repostType":2,"isVote":1,"tweetType":1,"viewCount":1941,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":884953731,"gmtCreate":1631849271923,"gmtModify":1676530652175,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02318\">$PING AN(02318)$</a>So much cash but still can’t stop your stock to plummet, it is a given to hold but still heartbreaking&nbsp;","listText":"<a href=\"https://laohu8.com/S/02318\">$PING AN(02318)$</a>So much cash but still can’t stop your stock to plummet, it is a given to hold but still heartbreaking&nbsp;","text":"$PING AN(02318)$So much cash but still can’t stop your stock to plummet, it is a given to hold but still heartbreaking","images":[{"img":"https://static.tigerbbs.com/0a4dfd51c94a1a77bbe1f8ecc7f5a701","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/884953731","isVote":1,"tweetType":1,"viewCount":2525,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3574968450404111","authorId":"3574968450404111","name":"Bloomberg Markets","avatar":"https://community-static.tradeup.com/news/f516c34a4c299ef7bfa6036707b67c4a","crmLevel":12,"crmLevelSwitch":1,"authorIdStr":"3574968450404111","idStr":"3574968450404111"},"content":"Your entry price is quite good. By Q1, 2022 you will see Green","text":"Your entry price is quite good. By Q1, 2022 you will see Green","html":"Your entry price is quite good. By Q1, 2022 you will see Green"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":881280570,"gmtCreate":1631343990190,"gmtModify":1676530533275,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"Like me :)","listText":"Like me :)","text":"Like me :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/881280570","repostId":"1147045390","repostType":4,"repost":{"id":"1147045390","kind":"news","pubTimestamp":1631321547,"share":"https://ttm.financial/m/news/1147045390?lang=en_US&edition=fundamental","pubTime":"2021-09-11 08:52","market":"us","language":"en","title":"Why Apple’s Risk Is Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=1147045390","media":"Barrons","summary":"Apple faces real, but limited, risk to its revenue and profits from Friday’s ruling that requires it to allow developers to offer alternative payment methods for purchases made in apps downloaded through the Apple app store.In a case filed by Fortnite publisher Epic Games, U.S. District Judge Yvonne Gonzalez Rogers issued a permanent injunction that requires Apple  to allow developers the option to include links to alternative payment methods in their apps. Apple’s own payment system takes a 30%","content":"<p>Apple faces real, but limited, risk to its revenue and profits from Friday’s ruling that requires it to allow developers to offer alternative payment methods for purchases made in apps downloaded through the Apple app store.</p>\n<p>In a case filed by Fortnite publisher Epic Games, U.S. District Judge Yvonne Gonzalez Rogers issued a permanent injunction that requires Apple (ticker: AAPL) to allow developers the option to include links to alternative payment methods in their apps. Apple’s own payment system takes a 30% cut from large developers.</p>\n<p>Data from the app tracker SensorTower shows that in calendar 2020, Apple had overall revenue from the App Store of $72.3 billion, generating an estimated $21.7 billion in fees, or about 7% of Apple’s overall revenues. That includes $21 billion in spending in the U.S., generating about $6.3 billion in fees, or about 2% of annualized revenues.</p>\n<p>SensorTower estimates that mobile-game spending in the App Store in calendar 2020 was $47.6 billion, generating $14.3 billion in fees, or a little under 5% of Apple’s total revenues.</p>\n<p>Gene Munster, managing director of the venture firm Loup Capital and a former sell-side analyst with a long history of tracking Apple, estimated that the App Store accounts for about 14% of the company’s profits. But he sees limited risk from Friday’s ruling.</p>\n<p>Munster thinks most app developers will stay inside of the Apple system. He sees “at most” a 2% headwind to overall revenue, and a potential 4% hit to profits.</p>\n<p>“After the first year of these changes, app store growth rates will return to normal,” he said. “Bottom line, it’s at most a one-year headwind and does not change the big picture of where Apple is going over the next 5 years.”</p>\n<p>Evercore ISI analyst Amit Daryanani said in a research note that the ruling is a setback for Apple, but that the eventual impact is likely to be manageable, given Apple has alternative ways to generate revenue from the store, including its growing in-store ad business. And he noted that Apple actually got a win on a bigger issue in the case: The judge rejected Epic’s assertion that the App Store is an illegal monopoly. Daryanani estimated the risk to Apple’s per-share earnings at 2% to 4%.</p>\n<p>Wedbush analyst Dan Ives told&nbsp;<i>Barron’s</i>&nbsp;he thinks the worst-case scenario is a 3% to 4% hit to revenues, describing the risk as a “rounding error.” While Ives said the Street had expected an across-the-board win for Apple, the mixed decision removes an overhang on the stock and that investors are likely relieved to put the issue to rest.</p>\n<p>The ruling is more a positive for companies like&nbsp;Spotify Technology&nbsp;and&nbsp;Match Group&nbsp;than it is a negative for Apple, he said. Apple stock fell 3.3% to $148.97&nbsp;on&nbsp;Friday, while Spotify and March gained 0.7% and&nbsp;4.2%, respectively.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Apple’s Risk Is Limited</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Apple’s Risk Is Limited\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-11 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-app-store-epic-51631304007?mod=hp_LEAD_1_B_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple faces real, but limited, risk to its revenue and profits from Friday’s ruling that requires it to allow developers to offer alternative payment methods for purchases made in apps downloaded ...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-app-store-epic-51631304007?mod=hp_LEAD_1_B_2\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.barrons.com/articles/apple-app-store-epic-51631304007?mod=hp_LEAD_1_B_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147045390","content_text":"Apple faces real, but limited, risk to its revenue and profits from Friday’s ruling that requires it to allow developers to offer alternative payment methods for purchases made in apps downloaded through the Apple app store.\nIn a case filed by Fortnite publisher Epic Games, U.S. District Judge Yvonne Gonzalez Rogers issued a permanent injunction that requires Apple (ticker: AAPL) to allow developers the option to include links to alternative payment methods in their apps. Apple’s own payment system takes a 30% cut from large developers.\nData from the app tracker SensorTower shows that in calendar 2020, Apple had overall revenue from the App Store of $72.3 billion, generating an estimated $21.7 billion in fees, or about 7% of Apple’s overall revenues. That includes $21 billion in spending in the U.S., generating about $6.3 billion in fees, or about 2% of annualized revenues.\nSensorTower estimates that mobile-game spending in the App Store in calendar 2020 was $47.6 billion, generating $14.3 billion in fees, or a little under 5% of Apple’s total revenues.\nGene Munster, managing director of the venture firm Loup Capital and a former sell-side analyst with a long history of tracking Apple, estimated that the App Store accounts for about 14% of the company’s profits. But he sees limited risk from Friday’s ruling.\nMunster thinks most app developers will stay inside of the Apple system. He sees “at most” a 2% headwind to overall revenue, and a potential 4% hit to profits.\n“After the first year of these changes, app store growth rates will return to normal,” he said. “Bottom line, it’s at most a one-year headwind and does not change the big picture of where Apple is going over the next 5 years.”\nEvercore ISI analyst Amit Daryanani said in a research note that the ruling is a setback for Apple, but that the eventual impact is likely to be manageable, given Apple has alternative ways to generate revenue from the store, including its growing in-store ad business. And he noted that Apple actually got a win on a bigger issue in the case: The judge rejected Epic’s assertion that the App Store is an illegal monopoly. Daryanani estimated the risk to Apple’s per-share earnings at 2% to 4%.\nWedbush analyst Dan Ives told Barron’s he thinks the worst-case scenario is a 3% to 4% hit to revenues, describing the risk as a “rounding error.” While Ives said the Street had expected an across-the-board win for Apple, the mixed decision removes an overhang on the stock and that investors are likely relieved to put the issue to rest.\nThe ruling is more a positive for companies like Spotify Technology and Match Group than it is a negative for Apple, he said. Apple stock fell 3.3% to $148.97 on Friday, while Spotify and March gained 0.7% and 4.2%, respectively.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":2769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815843482,"gmtCreate":1630669754846,"gmtModify":1676530371495,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"Just cause of some rare cases happening doesntmean jack lol","listText":"Just cause of some rare cases happening doesntmean jack lol","text":"Just cause of some rare cases happening doesntmean jack lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/815843482","repostId":"2164871841","repostType":2,"repost":{"id":"2164871841","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1630666361,"share":"https://ttm.financial/m/news/2164871841?lang=en_US&edition=fundamental","pubTime":"2021-09-03 18:52","market":"us","language":"en","title":"EMA Says Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot","url":"https://stock-news.laohu8.com/highlight/detail?id=2164871841","media":"T-Reuters","summary":"EMA:Ema: Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (Prac) 30 August – ","content":"<html><body><p>EMA:Ema: Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (Prac) 30 August – 2 September 2021: 03/09/2021.Ema Says  Covid-19 Vaccines: Ema Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot.Ema Says Some Cases Of Mis Were Also Reported In Eea Following Vaccination With Other Covid-19 Vaccines.Ema: At This Stage, There Is No Change To The Current Eu Recommendations For The Use Of Covid-19 Vaccines.Ema:   Prac Is Reviewing Data On Cases Of Venous Thromboembolism (Blood Clots In The Veins) With Covid-19 Vaccine Janssen..Ema - Will Now Assess Available Data On Mis To Determine Whether Condition Can Be Caused By Vaccine And Recommend Whether Any Changes To Product Info.Ema: Prac To Assess Additional Data From 2 Large Clinical Trials Of Vaccine, Which Are To Be Submitted Shortly By Marketing Authorisation Holder Of Vaccine Janssen.Ema - Prac Discussed A Direct Healthcare Professional Communication (Dhpc) Containing Important Safety Information For Imbruvica..Ema: Prac Reviewing Signal For Patients With Cll Currently Receiving Ibrutinib Plus Rituximab Together With Ace Inhibitor, Advises Reconsider Treatment Strategy.Ema Says Venous Thromboembolism Was Included In The Risk Management Plan For Covid-19 Vaccine Janssen As A Safety Issue To Be Investigated.Ema-For Patients With Cll On Ace-Inhibitors Who Have Not Yet Started Treatment With Ibrutinib Plus Rituximab, Treatment Strategy Should Be Reconsidered.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EMA Says Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEMA Says Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-09-03 18:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>EMA:Ema: Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (Prac) 30 August – 2 September 2021: 03/09/2021.Ema Says  Covid-19 Vaccines: Ema Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot.Ema Says Some Cases Of Mis Were Also Reported In Eea Following Vaccination With Other Covid-19 Vaccines.Ema: At This Stage, There Is No Change To The Current Eu Recommendations For The Use Of Covid-19 Vaccines.Ema:   Prac Is Reviewing Data On Cases Of Venous Thromboembolism (Blood Clots In The Veins) With Covid-19 Vaccine Janssen..Ema - Will Now Assess Available Data On Mis To Determine Whether Condition Can Be Caused By Vaccine And Recommend Whether Any Changes To Product Info.Ema: Prac To Assess Additional Data From 2 Large Clinical Trials Of Vaccine, Which Are To Be Submitted Shortly By Marketing Authorisation Holder Of Vaccine Janssen.Ema - Prac Discussed A Direct Healthcare Professional Communication (Dhpc) Containing Important Safety Information For Imbruvica..Ema: Prac Reviewing Signal For Patients With Cll Currently Receiving Ibrutinib Plus Rituximab Together With Ace Inhibitor, Advises Reconsider Treatment Strategy.Ema Says Venous Thromboembolism Was Included In The Risk Management Plan For Covid-19 Vaccine Janssen As A Safety Issue To Be Investigated.Ema-For Patients With Cll On Ace-Inhibitors Who Have Not Yet Started Treatment With Ibrutinib Plus Rituximab, Treatment Strategy Should Be Reconsidered.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164871841","content_text":"EMA:Ema: Meeting Highlights From The Pharmacovigilance Risk Assessment Committee (Prac) 30 August – 2 September 2021: 03/09/2021.Ema Says  Covid-19 Vaccines: Ema Reviewing Cases Of Multisystem Inflammatory Syndrome Relating To Pfizer Shot.Ema Says Some Cases Of Mis Were Also Reported In Eea Following Vaccination With Other Covid-19 Vaccines.Ema: At This Stage, There Is No Change To The Current Eu Recommendations For The Use Of Covid-19 Vaccines.Ema:   Prac Is Reviewing Data On Cases Of Venous Thromboembolism (Blood Clots In The Veins) With Covid-19 Vaccine Janssen..Ema - Will Now Assess Available Data On Mis To Determine Whether Condition Can Be Caused By Vaccine And Recommend Whether Any Changes To Product Info.Ema: Prac To Assess Additional Data From 2 Large Clinical Trials Of Vaccine, Which Are To Be Submitted Shortly By Marketing Authorisation Holder Of Vaccine Janssen.Ema - Prac Discussed A Direct Healthcare Professional Communication (Dhpc) Containing Important Safety Information For Imbruvica..Ema: Prac Reviewing Signal For Patients With Cll Currently Receiving Ibrutinib Plus Rituximab Together With Ace Inhibitor, Advises Reconsider Treatment Strategy.Ema Says Venous Thromboembolism Was Included In The Risk Management Plan For Covid-19 Vaccine Janssen As A Safety Issue To Be Investigated.Ema-For Patients With Cll On Ace-Inhibitors Who Have Not Yet Started Treatment With Ibrutinib Plus Rituximab, Treatment Strategy Should Be Reconsidered.","news_type":1,"symbols_score_info":{"PFE":1}},"isVote":1,"tweetType":1,"viewCount":1555,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818331188,"gmtCreate":1630374940244,"gmtModify":1676530284429,"author":{"id":"4088932361408620","authorId":"4088932361408620","name":"NicholasTK","avatar":"https://static.tigerbbs.com/245aef3e1629fe0fa454fb9d56eaca48","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4088932361408620","idStr":"4088932361408620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09901\">$NEW ORIENTAL-S(09901)$</a>Yeet","listText":"<a href=\"https://laohu8.com/S/09901\">$NEW ORIENTAL-S(09901)$</a>Yeet","text":"$NEW ORIENTAL-S(09901)$Yeet","images":[{"img":"https://static.tigerbbs.com/de5b25c111104916f787d3df6e5926da","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818331188","isVote":1,"tweetType":1,"viewCount":2268,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}